Clinical, immunological, and microbiological analysis of the association between periodontitis and COVID-19: a case-control study
Larissa Marques Bemquerer,Sicília Rezende Oliveira,José Alcides Almeida de Arruda,Fernanda Pereira Delgado Costa,Lucyene Miguita,Ana Luisa Marques Bemquerer,Ana Carolina Velasco Pondé de Sena,Alessandra Figueiredo de Souza,Daniel Fajardo Mendes,Ayda Henriques Schneider,Michelle de Campos Soriani Azevedo,Denise Vieira Travassos,Gustavo Pompermaier Garlet,Fernando de Queiroz Cunha,Renato Santana de Aguiar,Renan Pedra de Souza,Ricardo Santiago Gomez,Axel Spahr,Fabian Obregon-Miano,Lucas Guimarães Abreu,Fernando Oliveira Costa,Tarcília Aparecida Silva
DOI: https://doi.org/10.1007/s10266-023-00811-2
Odontology
Abstract:Purpose: Periodontitis and coronavirus disease (COVID-19) share risk factors and activate similar immunopathological pathways, intensifying systemic inflammation. This study investigated the clinical, immunological and microbiological parameters in individuals with COVID-19 and controls, exploring whether periodontitis-driven inflammation contributes to worsening COVID-19 endpoints. Methods: Case (positive RT-PCR for SARS-CoV-2) and control (negative RT-PCR) individuals underwent clinical and periodontal assessments. Salivary levels of TNF-α, IL-6, IL-1β, IL-10, OPG, RANKL, neutrophil extracellular traps, and subgingival biofilm were analyzed at two timepoints. Data on COVID-19-related outcomes and comorbidity information were evaluated from medical records. Results: Ninety-nine cases of COVID-19 and 182 controls were included for analysis. Periodontitis was associated with more hospitalization (p = 0.009), more days in the intensive care unit (ICU) (p = 0.042), admission to the semi-ICU (p = 0.047), and greater need for oxygen therapy (p = 0.042). After adjustment for confounders, periodontitis resulted in a 1.13-fold increase in the chance of hospitalization. Salivary IL-6 levels (p = 0.010) were increased in individuals with COVID-19 and periodontitis. Periodontitis was associated with increased RANKL and IL-1β after COVID-19. No significant changes were observed in the bacterial loads of the periodontopathogens Porphyromona gingivalis, Aggregatibacter actinomycetemcomitans, Tanerella forsythia, and Treponema denticola. Conclusions: Periodontitis was associated with worse COVID-19 outcomes, suggesting the relevance of periodontal care to reduce the burden of overall inflammation. Understanding the crosstalk between SARS-CoV-2 infection and chronic conditions such as periodontitis that can influence disease outcome is important to potentially prevent complications of COVID-19.